Oxidative stress in rat kidneys due to 3,4-methylenedioxymetamphetamine (ecstasy) toxicity

Nephrology

Volumn 13, Issue 1, 2008, Pages 33-37

  Ninković, Milica ^a   Selaković, Vesna ^a   Dukić, Mirjana ^b   Milosavljević, Petar ^a   Vasiljević, Ivana ^a   Jovanović, Marina ^a   Maličević, Živorad ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b Faculty of Pharmacy   (Serbia)

Author keywords

Kidney; Lipid peroxidation; MDMA; Oxidative stress

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE;

3,4-METHYLENEDIOXYAMPHETAMINE; ADMINISTRATION, ORAL; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; KIDNEY DISEASES; MALE; OXIDATIVE STRESS; RATS; SEVERITY OF ILLNESS INDEX; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 38149115550     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00886.x     Document Type: Article

References (35)

1. Kalant H. The pharmacology and toxicology of 'extasy' (MDMA) and related drugs. CMAJ 2001 165 : 917 28.
2. Malpass A, White JM, Irvine RJ, Somogyi AA, Bochner F. Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and dark Agoutin rats. Pharmacol. Toxicol. 1999 64 : 29 34.
3. Gowing LR, Henry-Edwards SM, Irwine RJ, Ali RL. The health effects of ecstasy: a literature review. Drug Alcohol Rev. 2002 21 : 53 63.
4. Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur. J. Pharmacol. 2002 446 : 89 96.
5. Slikker W, Holson RR, Ali SF et al. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 1989 10 : 529 42.
6. Irvine RJ, Toop NP, Phillis BD, Lewanowitsch T. The acute cardiovascular effects of 3,4 methlenedioxymetamphetamine (MDMA) and p-metoxyamphetamine (PMA). Addict. Biol. 2001 6 : 45 54.
7. De la Torre R, Farre M, Ortuno J et al. Non-linear pharmacokinetics of MDMA (ecstasy) in humans. Br. J. Clin. Pharmacol. 2000 49 : 104 9.
8. Lyles J, Cadet JL. Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain. Res. Rev. 2003 42 : 155 68.
9. Fleckenstein A, Wilkins DG, Gibb JW, Hanson GR. Interaction between hyperthermia and oxigen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Ther. 1997 283 : 281 5.
10. Carvalho M, Carvalho F, Remiao F et al. Effect of 3,4- methylenedioxymethamphetamine ecstasy on body temperature and liver antioxidant status in mice: influence of ambient temperature. Arch. Toxicol. 2002 76 : 166 72.
11. Fahal IB, Sallomi DF, Yaqoob M, Bell GM. Acute renal failure after extasy. BMJ 1992 305 : 29.
12. Kunsdorf-Wnuk A, Musiol E, Karpel E, Arct-Danielak D. Rhabdomyolysis, disseminated intravascular coagulation and acute renal failure after severe narcotics intoxication (MDMA, THC, amphetamine). Pol. Merkur. Lekarski 2005 18 : 436 9.
13. Ninković M, Maličević Ž, Selaković V, Simić I, Vasiljević I. N-Methyl-3,4-methylenedioxyamphetamine- induced hepatotoxicity in rats: oxidative stress after acute and chronic administration. Vojnosanit. Pregl. 2004 61 : 125 31.
14. Uputstvo za dobru laboratorijsku praksu. Sluzbeni List SRJ 2001 40 : 1 15.
15. McFadden K, Gillespie J, Carney B, O'driscoll D. Development and application of a high-perfomance liquid chromatography method using monolithic. Brain. Res. Rev. 2003 42 : 155 68.
16. Lyles J, Cadet JL. Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res. Rew. 2003 42 : 155 68.
17. Gurd JW, Jones LR, Mahler HR, Moore WJ. Isolation, and partial characterization of rat brain synaptic plasma membranes. J. Neurochem. 1974 22 : 281 90.
18. Lowry OH, Passonneau JV (eds). A Flexible System of Enzymatic Analysis, 2nd edn. New York : Academic Press, 1974.
19. Sun M, Zigman S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autooxidation. Anal. Biochem. 1978 90 : 81 9.
20. Mizuno Y, Ohta K. Regional distributions of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains. J. Neurochem. 1986 46 : 1344 52.
21. Kwon C, Zaritsky A, Dharnidharka VR. Transient proximal tubular renal injury following ecstasy ingestion. Pediatr. Nephrol. 2003 18 : 820 2.
22. Kreth KP, Kovar KA, Schwab M, Zanger UM. Identification of the human cytochromes P450 involved in the oxidative metabolism of 'extasy'-related designer drugs. Biochem. Pharmacol. 2000 59 : 1563 71.
23. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem. Res. Toxicol. 2001 3 : 135 60.
24. Carvalho M, Hawksworth G, Milhazes N et al. Role of metabolites in MDMA (extasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells. Arch. Toxicol. 2002 76 : 581 8.
25. Bredt DS, Snyder SH. Nitric oxide: a physiological messenger molecule. Annu. Rev. Biochem. 1994 63 : 175 95.
26. Taraska T, Finnegan KT. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 1997 280 : 941 7.
27. Aulak KS, Miyagi M, Yan L et al. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. PNAS 2001 98 : 12056 61.
28. Ishigami A, Tokunada I, Gotohda T, Kubo S. Immunohistochemical study of myoglobin and oxidative injury/related markers in the kidney of methamphetamine abusers. Leg. Med. (Tokyo) 2003 5 : 42 8.
29. Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolisis. Intensive Care Med. 2001 27 : 803 11.
30. Malberg JE, Seiden LS. Small changes in ambient temperature cause large changes in 3,4-(MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J. Neurosci. 1998 18 : 5086 94.
31. Sprague JE, Banks ML, Cook VJ, Mills EM. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). J. Pharmacol. Exp. Ther. 2003 305 : 159 66.
32. Maldonado E, Navarro JF. MDMA ('extasy') exhibits an anxiogenic-like activity in social encounters between male mice. Pharm. Res. 2001 44 : 1096 186.
33. Cole JC, Sumnall HR. Altered states: the clinical effects of ecstasy. Pharmacol. Ther. 2003 98 : 35 58.
34. Shankaran M, Yamamoto BK, Gudelsky GA. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum. J. Neurochem. 1999 72 : 2516 22.
35. Darvesh AS, Shankaran M, Gudelsky GA. Methylenedioxymethamphetamine produces glycogenolisis and increases the extracellular concentration of glucose in the rat brain. J. Pharmacol. Exp. Ther. 2002 301 : 138 44.